Skip to content

Jeevantyadi Ghrita for external application in eyes for cylindrical(with degree) type of spax.

" A CLINICAL STUDY ON THE EFFICACY OF JIVANTYADI GHRITA NETRA TARPANA AND CHITRAKADI GHANA VATI IN THE MANAGEMENT OF VATAJA TIMIRA W.S.R. ASTIGMATISM ."

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/08/003861
Enrollment
48
Registered
2013-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with acquired Astigmatism with development

Interventions

Intervention1: Jivantyadi Ghrita Go Ghrita Eye Exercises: ï?¶ Group A: After preparatory phase, Tarpana with Jivantyadi Ghrita(approx. 20 â?? 20 ml of Ghrita for each eye) for 5 days in 3 sittings w

Sponsors

IPGT AND RA GAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing symptoms of Vataja Timira & Astigmatism, viz. 1. Bhramanteeva roopa - Illusionary visual perception. 2. Aaavila roopa - objects appears hazy (Diminished visual perception). 3. Arunaabha roopa - objects appears reddish. 4. Vyaviddha roopa - objects appears distorted-tortuous or altered shaped. 5. Asthenopic symptoms viz. frontal/brow headache, pain around the eye, early tiredness of eyes,watering from eyes, drowsiness, nausea, migraine, vertigo, fatigue. 6. Patients between the age of 8 to 30 yrs. 7. Patients of Astigmatism with Cylindrical Dioptric value between 0.50 to 7.00 D.

Exclusion criteria

Exclusion criteria: Patient having any lenticular or corneal opacity and other known ocular pathology for e.g. Vitreous and Retinal diseases(not any degeneration), glaucoma etc will be excluded from the study. Astigmatism due to non-corneal pathology(i.e. Lenticular or Retinal) are excluded from the study. Patients age 30 yrs. Patients of Astigmatism with Cylindrical Dioptric value 7.00 D.

Design outcomes

Primary

MeasureTime frame
rather than justTimepoint: upto present study

Secondary

MeasureTime frame
rather than justTimepoint: upto present study

Countries

India

Contacts

Public ContactDr Jay Shah

IPGT AND RA, G.A.U. JAMNAGAR

dr_ks_dhiman@yahoo.co.in9723821965

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026